For the first​ time​ in ‌decades, researchers have discovered a new class of antibiotics that could effectively ‍combat superbacteria—some of the bacteria most resistant to medications.

The revelation occurred serendipitously.The molecule was found in soil samples collected from a laboratory technician’s garden, highlighting⁤ the potential for undiscovered compounds in everyday environments. According to one microbiologist, kim Lewis, this shows ​that there are incredibly interesting things hidden with the naked eye. Lewis is from Northeastern University in Boston, massachusetts, and was not involved in the investigation.

This breakthrough represents an initial step​ toward developing new antimicrobial medications with the potential to treat life-threatening diseases, ranging ‌from pneumonia to urinary tract infections.

The research team published its findings in the journal Nature.

Scientists found that a bacteria ​strain,⁤ called ⁢paenibacillus, produced a ​novel class of antibiotics: a chemical compound called lariocidine.

Lariocidine has demonstrated effectiveness against multidrug-resistant bacteria, posing a significant threat to public health, explained Boch Jangra, an ⁣author of the study.

The finding‍ follows a 2023 warning from the World Health Organization that antimicrobial resistance is ‍a major global health threat. Estimates suggest that antibiotic ⁣resistance caused over 4.5⁣ million ⁣deaths in⁢ 2019. A study published in The Lancet indicated that⁢ in 2023,⁤ 24,000 people in Spain died due to multi-resistant bacteria.

The antibiotic resistance crisis is an existential threat‌ to medicine, said Gerry Wright, co-author of the study.

Protein Factory

The new ‍molecule targets the ribosome, the protein factory of bacteria, in a way that differs ⁢from existing antibiotics. The ⁢ribosome ⁢is an attractive target⁣ because bacteria are less likely to develop resistance‌ to​ drugs targeting its structure.

Lariocidine, a loop-shaped peptide, possesses ⁣a ⁢unique structure compared to othre antibiotics. This allows it​ to bind to the ribosome and prevent⁣ bacteria⁢ from producing proteins essential for their ‍survival, ultimately leading to cell death, Wright⁤ explained.

Furthermore, studies revealed​ that lariocidine is non-toxic⁣ to human cells⁢ and showed efficacy ⁤in tests involving mice. However, Wright cautioned that further research is necessary to confirm the antibiotic’s safety in ⁢humans.

Researchers infected mice with Acinetobacter Baumannii, a‍ highly resistant and lethal pathogen that has developed resistance to most antibiotics.

This pathogen ⁣can cause pneumonia, urinary tract infections, bloodstream infections,‌ and⁤ wound infections. Its‍ spread⁣ can lead​ to septic shock and multi-organ failure. Immunocompromised ​individuals⁢ are particularly⁤ vulnerable to complications and ⁢death from this bacterium, commonly found in hospital environments.

Mice treated with lariocidine survived,while untreated mice died within 24 to 28 hours,Jangra said.

Future Research

Researchers are now working on methods to modify the lariocidine produced by bacteria and increase its⁣ production, aiming to⁣ develop a more potent medication‍ suitable for human trials to ⁣treat skin,‌ lung, and bloodstream infections.

Wright stated that he and his colleagues are focused on enhancing ⁣the molecule’s effectiveness as a potential drug. As a newly discovered [molecule], it is quite⁣ good, he said, but ⁣the ​goal is to ​increase ⁢its potency to reduce the required dosage. He added that⁤ extensive research is needed ‌before​ the molecule can be used as​ a human drug, including studies on its ‍accumulation and excretion within the body.

According to Rafael Cantón,Head ⁣of the Microbiology Service,the discovery of lariocidine,an antibiotic that acts differently from existing ones,is an vital advance. ⁤ But, even though promising, it still needs clinical ⁤trials to​ confirm its effectiveness and safety.